Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy.

Turner D, Walsh CM, Benchimol EI, Mann EH, Thomas KE, Chow C, McLernon RA, Walters TD, Swales J, Steinhart AH, Griffiths AM.

Gut. 2008 Mar;57(3):331-8. Epub 2007 Nov 2.

PMID:
17981888
2.
3.

The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.

Egesten A, Eliasson M, Olin AI, Erjefält JS, Bjartell A, Sangfelt P, Carlson M.

Int J Colorectal Dis. 2007 Dec;22(12):1421-7. Epub 2007 Aug 17.

PMID:
17703315
4.

Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages.

Voehringer D, van Rooijen N, Locksley RM.

J Leukoc Biol. 2007 Jun;81(6):1434-44. Epub 2007 Mar 5.

PMID:
17339609
5.

Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.

Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S.

Inflamm Bowel Dis. 2007 Jul;13(7):807-21.

PMID:
17262812
6.

Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study).

Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold Ø, Schulz T, Vatn MH, Moum B; IBSEN Study Group.

Inflamm Bowel Dis. 2006 Jul;12(7):543-50.

PMID:
16804390
7.

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Satsangi J, Silverberg MS, Vermeire S, Colombel JF.

Gut. 2006 Jun;55(6):749-53.

8.

The eosinophil.

Rothenberg ME, Hogan SP.

Annu Rev Immunol. 2006;24:147-74. Review.

PMID:
16551246
9.

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME.

J Clin Invest. 2006 Feb;116(2):536-47.

10.

The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis.

Park YR, Choi SC, Lee ST, Kim KS, Chae SC, Chung HT.

Exp Mol Med. 2005 Dec 31;37(6):553-8.

11.

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.

Fichtner-Feigl S, Fuss IJ, Preiss JC, Strober W, Kitani A.

J Clin Invest. 2005 Nov;115(11):3057-71. Epub 2005 Oct 20.

12.

The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia.

Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME.

J Immunol. 2005 Oct 15;175(8):5341-50.

13.

Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation.

Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, Zimmermann N, Molkentin JD, Rothenberg ME.

J Biol Chem. 2005 Apr 8;280(14):13952-61. Epub 2005 Jan 12.

14.

Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa.

Papadakis KA, Prehn J, Zhu D, Landers C, Gaiennie J, Fleshner PR, Targan SR.

Inflamm Bowel Dis. 2004 Nov;10(6):778-88.

PMID:
15626897
15.

Defining a link with asthma in mice congenitally deficient in eosinophils.

Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA.

Science. 2004 Sep 17;305(5691):1773-6.

16.

At the crossroads of inflammation and cancer.

Clevers H.

Cell. 2004 Sep 17;118(6):671-4. Review.

17.

Seeing red in inflammatory bowel disease: the eosinophil at center stage?

Miner PB Jr.

Inflamm Bowel Dis. 2004 May;10(3):329-30. No abstract available.

PMID:
15290934
18.

Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases.

Robert ME, Skacel M, Ullman T, Bernstein CN, Easley K, Goldblum JR.

Am J Clin Pathol. 2004 Jul;122(1):94-9.

PMID:
15272536
19.

T helper-2 immunity regulates bronchial hyperresponsiveness in eosinophil-associated gastrointestinal disease in mice.

Forbes E, Smart VE, D'Aprile A, Henry P, Yang M, Matthaei KI, Rothenberg ME, Foster PS, Hogan SP.

Gastroenterology. 2004 Jul;127(1):105-18.

PMID:
15236177
20.

Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.

Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA.

Science. 2004 Jun 11;304(5677):1678-82.

Supplemental Content

Support Center